Text Module


Share

Program Content

Activities

  • BTKi Resistance in CLL
    A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 01, 2024

    Expires: March 31, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca

AstraZeneca